Clinical Trials
7 trialsNCT07324629 2026-05-07
Sacituzumab Tirumotecan in Participants With Locally Advanced or Metastatic Thymic Carcinoma
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 2 Not yet recruiting
NCT04321330 2024-06-11
A Study to Investigate the Efficacy and Safety of Atezolizumab (Tecentriq) in Previously-Treated Patients With Advanced Thymic Carcinoma
Hoffmann-La Roche
Phase 2 Completed
NCT04469725 2024-03-12
KN046 (a Humanized PD-L1/CTLA4 Bispecific Single Domain Fc Fusion Protein Antibody) in Subjects With Thymic Carcinoma
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Phase 2 Terminated
NCT01011439 2019-02-06
Phase II Study Of Oral PHA-848125AC In Patients With Thymic Carcinoma
Tiziana Life Sciences LTD
Phase 2 Terminated
NCT01301391 2019-02-06
Study Of Oral PHA-848125AC In Patients With Malignant Thymoma Previously Treated With Multiple Lines Of Chemotherapy
Tiziana Life Sciences LTD
Phase 2 Terminated
NCT00332969 2017-03-31
Efficacy of Octreotide Treatment in Patients With Primary Inoperable Thymoma
Novartis
Phase 2 Completed
NCT00154388 2016-11-18
Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases
Novartis
Phase 2 Completed